Gene · 9260
Papers4,249
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 4,249
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| p16INK4a and pRb expression in laryngeal squamous cell carcinoma with and without infection by EBV or different genotypes of HPV: a retrospective study. | Infect Agent Cancer | 2023 | 37434200 | PubTator, text mining | PubMed |
| Inhibitory NKG2A+ and absent activating NKG2C+ NK cell responses are associated with the development of EBV+ lymphomas. | Front Immunol | 2023 | 37426645 | PubTator, text mining | PubMed |
| Immunotherapy for nasopharyngeal carcinoma: Current status and prospects (Review). | Int J Oncol | 2023 | 37417358 | PubTator, text mining | PubMed |
| Epstein‑Barr virus as a promoter of tumorigenesis in the tumor microenvironment of breast cancer (Review). | Int J Mol Med | 2023 | 37417334 | PubTator, text mining | PubMed |
| Oncogenic SRSF3 in health and diseases. | Int J Biol Sci | 2023 | 37416784 | PubTator, text mining | PubMed |
| Small non-coding RNAs encoded by RNA viruses: old controversies and new lessons from the COVID-19 pandemic. | Front Genet | 2023 | 37415603 | PubTator, text mining | PubMed |
| Changes in SUMO-modified proteins in Epstein-Barr virus infection identifies reciprocal regulation of TRIM24/28/33 complexes and the lytic switch BZLF1. | PLoS Pathog | 2023 | 37410772 | PubTator, text mining | PubMed |
| Immunodeficiency with susceptibility to lymphoma with complex genotype affecting energy metabolism (FBP1, ACAD9) and vesicle trafficking (RAB27A). | Front Immunol | 2023 | 37388727 | PubTator, text mining | PubMed |
| α-catenin interaction with YAP/FoxM1/TEAD-induced CEP55 supports liver cancer cell migration. | Cell Commun Signal | 2023 | 37381005 | PubTator, text mining | PubMed |
| Onco-Pathogen Mediated Cancer Progression and Associated Signaling Pathways in Cancer Development. | Pathogens | 2023 | 37375460 | PubTator, text mining | PubMed |
| Novel Bifunctional Affibody Molecules with Specific Binding to Both EBV LMP1 and LMP2 for Targeted Therapy of Nasopharyngeal Carcinoma. | Int J Mol Sci | 2023 | 37373272 | PubTator, text mining | PubMed |
| Feature Reviews of the Molecular Mechanisms of Nasopharyngeal Carcinoma. | Biomedicines | 2023 | 37371623 | PubTator, text mining | PubMed |
| Worldwide Prevalence of Epstein-Barr Virus in Patients with Burkitt Lymphoma: A Systematic Review and Meta-Analysis. | Diagnostics (Basel) | 2023 | 37370963 | PubTator, text mining | PubMed |
| Integrated bioinformatics and wet-lab analysis revealed cell adhesion prominent genes CDC42, TAGLN and GSN as prognostic biomarkers in colonic-polyp lesions. | Sci Rep | 2023 | 37365287 | PubTator, text mining | PubMed |
| Weaving the nest: extracellular matrix roles in pre-metastatic niche formation. | Front Oncol | 2023 | 37350937 | PubTator, text mining | PubMed |
| Sporadic late onset nemaline myopathy with concurrent dermatological symptoms responding to immunosuppressive treatment. | BMC Neurol | 2023 | 37328820 | PubTator, text mining | PubMed |
| The role of extracellular vesicles in the development of nasopharyngeal carcinoma and potential clinical applications. | Cancer Med | 2023 | 37306659 | PubTator, text mining | PubMed |
| Role of p53 suppression in the pathogenesis of hepatocellular carcinoma. | World J Gastrointest Pathophysiol | 2023 | 37304923 | PubTator, text mining | PubMed |
| A Rare Case of Primary Anorectal Hodgkin Lymphoma in an HIV-Positive Patient: A Case Report and Literature Review. | Cureus | 2023 | 37303441 | PubTator, text mining | PubMed |
| Oncogenic Viruses and the Epigenome: How Viruses Hijack Epigenetic Mechanisms to Drive Cancer. | Int J Mol Sci | 2023 | 37298494 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9260/papers?page=15